• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: LIVANOVA CANADA CORP PERCEVAL SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

LIVANOVA CANADA CORP PERCEVAL SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVE Back to Search Results
Model Number PVS23
Device Problem Difficult to Fold, Unfold or Collapse (1254)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 05/22/2019
Event Type  Injury  
Manufacturer Narrative
The returned pvs valve was received in generally good condition.Investigation is ongoing.
 
Event Description
An attempt was made to implant a perceval valve; however, problems were encountered during the collapsing procedure.It was reported the perceval pvs23 could not be collapsed because the outflow stent did not collapse completely and could not be covered by the plastic sheath.In an attempt to address the issue, a large accessory kit was opened, but could not collapse the valve either.A new valve was then opened.Difficulty was also encountered during the attempted collapse of the second valve (the second valve is reported in a separate event, (b)(4)).Ultimately, a traditional sutured valve was implanted.The patient had no adverse consequences as a result of the event, but the procedure was delayed by at least 20-25 minutes.
 
Manufacturer Narrative
After decontamination, a visual inspection was performed.The results confirmed the absence of pre-existing defects.The simulation of the valve collapsing, performed with the returned device and a demo accessory kit was completed with no difficulties.Furthermore, he manufacturing and material records for the perceval heart valve, model #icv1209 , s/n # (b)(6), as they pertain to the reported event, were retrieved and reviewed by quality engineering.The results confirmed that this valve satisfied all material, visual, and performance standards required for a (model #icv1209) perceval heart valve at the time of manufacture and release.Based on the performed analysis, the reported collapsing difficulties were not observed during the collapsing replication and then cannot be explained by any factor intrinsic in the involved device.The possible root cause can be related to the valve positioning too far forward in the dual collapser leading a lack on contact between the outflow crown and the internal teeth of the dual collapser; this aspect makes it impossible to properly collapse the valve.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PERCEVAL SUTURELESS AORTIC HEART VALVE
Type of Device
TISSUE HEART VALVE
Manufacturer (Section D)
LIVANOVA CANADA CORP
5005 north fraser way
burnaby, bc
MDR Report Key8701883
MDR Text Key148146864
Report Number3004478276-2019-00190
Device Sequence Number1
Product Code LWR
UDI-Device Identifier00896208000429
UDI-Public(01)00896208000429(240)ICV1209(17)220419
Combination Product (y/n)N
PMA/PMN Number
P150011
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup
Report Date 07/19/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date04/19/2022
Device Model NumberPVS23
Device Catalogue NumberICV1209
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer06/03/2019
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 05/22/2019
Initial Date FDA Received06/14/2019
Supplement Dates Manufacturer Received06/26/2019
Supplement Dates FDA Received07/19/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age80 YR
Patient Weight78
-
-